AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2014
Jun 24, 2014
35124_dirs_2014-06-24_675747a3-57f1-44e8-baad-339346b2eaad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2014-06-20
Reporting Person: Hooper Robert W (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-06-20 | Option to Purchase Celsion Corporation Common Stock | $3.50 | A | 30000 | Acquired | 2024-06-20 | Celsion Corporation Common Stock (30000) | Direct |
Footnotes
F1: Represents the closing price of Celsion Corporation Common Stock on the date of grant.
F2: The option vests in thirds on June 20, 2014, June 20, 2015 and June 20, 2016.
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18